AJOVista’s Inhibrx, Inc. Common Stock INBX Stock Holding History

AJOVista’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-678	Closed	-$25.8K	–	459
2023 Q4	$25.8K	Buy	+678	New	+$14.5K	0.03%	341

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AJOVista's INBX Position: Q1 2024 in Review

AJOVista sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 678 shares — an estimated $25.8K sold.

AJOVista first reported a position in INBX in Q4 2023 and held it in 1 quarter. The position peaked at $25.8K in Q4 2023. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

AJOVista reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AJOVista sold 678 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $25.8K.
AJOVista first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
AJOVista's Inhibrx, Inc. Common Stock position peaked at $25.8K in Q4 2023.
126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.